Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

760188

	registered interest
	date	13/09/2017
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Scottish Limited Partnerships
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many Scottish limited partnerships are qualifying under the terms of the Scottish Partnerships (Register of People with Significant Control) Regulations 2017 and the Companies and Partnerships (Accounts and Audit) Regulations 2013.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	10329
	answer	answer is ministerial correction date of answer 12/10/2017 answer text <p>As I stated in the answer to Question UIN 10360, there are approximately 33,000 Scottish Limited Partnerships (SLPs) registered with Companies House. All registered SLPs are eligible under the terms of the Scottish Partnerships (Register of People with Significant Control) Regulations 2017.</p><p> </p><p>The above regulations also require a Scottish qualifying partnership (SQP) to register with Companies House and deliver information concerning its People with Significant Control (PSC). An SQP is a general partnership constituted under the law of Scotland that is a qualifying partnership under the Partnership (Accounts) Regulations 2008. As of 22 September 2017, 493 SQPs have delivered PSC information to Companies House.</p> answering member constituency Stourbridge answering member printed Margot James question first answered 12/10/2017 14:04:51 answering member 4115 label Biography information for Margot James
	tabling member	4430 label Biography information for Alison Thewliss

760189

	registered interest
	date	13/09/2017
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Scottish Limited Partnerships
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many Scottish limited partnerships are eligible under the terms of the Scottish Partnerships (Register of People with Significant Control) Regulations 2017.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	10360
	answer	answer is ministerial correction date of answer 09/10/2017 answer text <p>There are approximately 33,000 Scottish Limited Partnerships (SLPs) registered with Companies House. All registered SLPs are eligible under the terms of the Scottish Partnerships (Register of People with Significant Control) Regulations 2017.</p> answering member constituency Stourbridge answering member printed Margot James question first answered 09/10/2017 16:39:23 answering member 4115 label Biography information for Margot James
	tabling member	4430 label Biography information for Alison Thewliss

765644

	registered interest
	date	06/10/2017
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	UK Visas and Immigration: Lost Property
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, how many applicants have documents recorded as lost by UK Visas and Immigration in each year since 2010.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	105855
	answer	answer is ministerial correction date of answer 17/10/2017 answer text <p>The specific data requested is not published by the Home Office.</p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 17/10/2017 15:26:51 answering member 4009 label Biography information for Sir Brandon Lewis
	tabling member	4430 label Biography information for Alison Thewliss

765645

	registered interest
	date	06/10/2017
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	UK Visas and Immigration: Lost Property
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, how much compensation has been paid to applicants for documents recorded as lost by UK Visas and Immigration in each year since 2010.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	105856
	answer	answer is ministerial correction date of answer 16/10/2017 answer text <p>This information is not centrally recorded.</p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 16/10/2017 14:59:36 answering member 4009 label Biography information for Sir Brandon Lewis
	tabling member	4430 label Biography information for Alison Thewliss

781428

	registered interest
	date	31/10/2017
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	UK Visas and Immigration: Lost Property
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, pursuant to the Answer of 17 October 2017 to Question 105855, what information her Department holds on the number of people who have registered complaints for the loss of documents by UK Visas and Immigration in each of the last seven years.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	110694
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The following information is available at <a href="https://www.gov.uk/government/collections/migration-transparency-data" target="_blank">https://www.gov.uk/government/collections/migration-transparency-data</a></p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 07/11/2017 16:14:11 answering member 4009 label Biography information for Sir Brandon Lewis
	tabling member	4430 label Biography information for Alison Thewliss

781454

	registered interest
	date	31/10/2017
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Department for Work and Pensions: Employment Tribunals Service
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, on how many occasions his Department has been taken to an employment tribunal for maternity discrimination in each year since 2010.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	110703
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>There have been 5 employment tribunal cases raised in the Department for Work and Pensions since 2010 – one case in 2010, one case in 2013 and three cases in 2016.</p><p> </p><p>These cases have been recorded under the category of Maternity and Parental Leave Regulations. Two of these are still active.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 03/11/2017 12:56:38 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4430 label Biography information for Alison Thewliss

782859

	registered interest
	date	02/11/2017
	answering body	Northern Ireland Office
	answering dept id	21
	answering dept short name	Northern Ireland
	answering dept sort name	Northern Ireland
	hansard heading	Northern Ireland Office: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Northern Ireland, when he plans to respond to the letter of 4 July 2017 from the British Association of Social Workers on universal credit specific circumstances and the Criminal Law Act (Northern Ireland) 1967.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	111057
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>A response to the British Association of Social Workers will issue this week.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 07/11/2017 10:44:40 answering member 1609 label Biography information for Chloe Smith
	tabling member	4430 label Biography information for Alison Thewliss

788559

	registered interest
	date	13/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to ensure access to cross-border clinical trial data after the UK leaves the EU.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	112739
	answer	answer is ministerial correction date of answer 16/11/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and NHS have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>The UK anticipates continuing to work with EU partners on sharing of clinical data across borders where applicable under legal frameworks and with the consent of the data subject. While we cannot pre-empt the outcome of the negotiations on the UK’s exit from the EU, our aim will be to ensure that patients continue to access the best and most innovative medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 112740 112741 question first answered 16/11/2017 12:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4430 label Biography information for Alison Thewliss

788560

	registered interest
	date	13/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he has taken to prepare for the implementation of the EU Clinical Trials Regulation in 2019.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	112740
	answer	answer is ministerial correction date of answer 16/11/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and NHS have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>The UK anticipates continuing to work with EU partners on sharing of clinical data across borders where applicable under legal frameworks and with the consent of the data subject. While we cannot pre-empt the outcome of the negotiations on the UK’s exit from the EU, our aim will be to ensure that patients continue to access the best and most innovative medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 112739 112741 question first answered 16/11/2017 12:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4430 label Biography information for Alison Thewliss

788561

	registered interest
	date	13/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to maintain access to new medicines from clinical trials after the UK leaves the EU.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	112741
	answer	answer is ministerial correction date of answer 16/11/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and NHS have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>The UK anticipates continuing to work with EU partners on sharing of clinical data across borders where applicable under legal frameworks and with the consent of the data subject. While we cannot pre-empt the outcome of the negotiations on the UK’s exit from the EU, our aim will be to ensure that patients continue to access the best and most innovative medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 112739 112740 question first answered 16/11/2017 12:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4430 label Biography information for Alison Thewliss